ELF

e.l.f. Beauty, Inc. NYSE

Consumer Defensive ·Household & Personal Products ·US · elfcosmetics.com

$61.85

After hrs $59.94 +0.88%

Mkt Cap $3.7B

52w Low $58.05 4.1% of range 52w High $150.99

50d MA $71.93 200d MA $96.44

P/E (TTM) 30.4x

EV/EBITDA 17.9x

P/B 4.5x

Debt/Equity 0.4x

ROE 4.3%

P/FCF 30.6x

RSI (14) —

ATR (14) —

Beta 2.39

50d MA $71.93

200d MA $96.44

Avg Volume 2.4M

About

e.l.f. Beauty, Inc., together with its subsidiaries, provides cosmetic and skin care products under the e.l.f. Cosmetics, e.l.f. Skin, Well People, and Keys Soulcare brand names worldwide. The company offers eye, lip, face, face, paw, and skin care products. It sells its products through national and international retailers and direct-to-consumer channels, which include e-commerce platforms in the…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 4, 2026	AMC	0.73	1.24	+69.9%	84.63	+8.7%	-9.2%	-3.0%	-12.0%	-13.4%	-9.2%	—
Nov 5, 2025	AMC	0.57	0.68	+19.9%	117.83	-24.1%	-35.0%	-37.4%	-32.2%	-33.8%	-34.0%	—
Aug 6, 2025	AMC	0.84	0.89	+6.5%	110.39	-11.5%	-9.5%	-7.8%	+1.2%	+5.8%	+11.4%	—
May 28, 2025	AMC	0.72	0.78	+8.2%	90.50	+20.3%	+23.6%	+24.3%	+25.7%	+26.8%	+29.5%	—
Feb 6, 2025	AMC	0.76	0.74	-2.6%	88.49	-25.1%	-19.6%	-16.5%	-13.1%	-15.2%	-15.3%	—
Aug 8, 2024	AMC	0.84	1.10	+31.0%	187.95	-11.0%	-14.4%	-23.6%	-20.9%	-22.6%	-17.2%	—
May 22, 2024	AMC	0.33	0.53	+59.6%	155.63	+11.0%	+18.7%	+23.0%	+24.2%	+18.1%	+17.2%	—
Feb 6, 2024	AMC	0.57	0.74	+29.6%	173.32	-1.2%	-4.9%	-1.0%	+0.7%	-0.8%	-3.2%	—
Nov 1, 2023	AMC	0.53	0.82	+55.9%	94.54	+11.7%	+3.7%	+1.7%	+7.6%	+7.9%	+3.8%	—
Aug 1, 2023	AMC	0.56	1.10	+96.4%	116.50	+15.5%	+14.3%	+13.4%	+10.0%	+12.4%	+12.9%	—
May 24, 2023	AMC	0.20	0.42	+113.7%	86.45	+10.7%	+20.5%	+17.2%	+21.4%	+20.3%	+23.2%	—
Feb 1, 2023	AMC	0.23	0.48	+106.2%	58.51	+18.4%	+15.0%	+19.2%	+17.4%	+23.1%	+22.3%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
May 1	Morgan Stanley	Downgrade	Overweight → Equal Weight	—	$63.97	$63.10	-1.4%	-5.4%	—	—	—	—
May 1	Morgan Stanley	Downgrade	Overweight → Equal-Weight	$67	$63.97	$63.10	-1.4%	-5.4%	—	—	—	—
Apr 28	Baird	Maintains	Outperform → Outperform	—	$63.72	$63.00	-1.1%	-1.1%	-4.1%	+0.4%	-5.1%	—
Apr 17	JP Morgan	Maintains	Overweight → Overweight	—	$69.25	$70.94	+2.4%	-3.5%	-1.2%	-3.3%	-5.3%	-4.4%
Apr 15	Citigroup	Maintains	Buy → Buy	—	$68.90	$69.15	+0.4%	+1.4%	+0.5%	-3.0%	-0.7%	-2.8%
Apr 10	BofA Securities	Maintains	Buy → Buy	—	$63.93	$63.73	-0.3%	+1.9%	+2.6%	+7.8%	+9.3%	+8.3%
Apr 7	UBS	Maintains	Neutral → Neutral	—	$63.22	$62.32	-1.4%	-3.3%	-2.3%	+1.1%	+3.0%	+3.8%
Mar 30	Deutsche Bank	Maintains	Hold → Hold	—	$61.05	$61.31	+0.4%	-2.8%	-0.7%	+2.0%	+0.2%	+3.6%
Feb 9	TD Cowen	Maintains	Buy → Buy	—	$82.09	$81.78	-0.4%	-9.3%	-10.8%	-6.4%	-9.5%	-0.7%
Feb 5	JP Morgan	Maintains	Overweight → Overweight	—	$84.63	$92.00	+8.7%	-9.2%	-3.0%	-12.0%	-13.4%	-9.2%
Feb 5	Citigroup	Maintains	Buy → Buy	—	$84.63	$92.00	+8.7%	-9.2%	-3.0%	-12.0%	-13.4%	-9.2%
Feb 5	UBS	Maintains	Neutral → Neutral	—	$84.63	$92.00	+8.7%	-9.2%	-3.0%	-12.0%	-13.4%	-9.2%
Jan 21	TD Cowen	Maintains	Buy → Buy	—	$89.04	$90.98	+2.2%	+3.1%	+5.1%	+5.8%	-0.3%	-2.6%
Jan 14	UBS	Maintains	Neutral → Neutral	—	$87.56	$87.08	-0.5%	-1.5%	+1.9%	+2.8%	+1.7%	+4.9%
Dec 22	Piper Sandler	Maintains	Neutral → Neutral	—	$80.44	$80.08	-0.4%	-1.6%	-2.5%	-0.8%	-0.0%	-1.3%
Dec 18	JP Morgan	Maintains	Overweight → Overweight	—	$78.85	$79.85	+1.3%	-2.0%	+2.0%	+0.4%	-0.5%	+1.2%
Nov 7	Goldman Sachs	Maintains	Buy → Buy	—	$76.54	$75.65	-1.2%	-3.7%	+4.3%	+1.9%	+1.6%	-2.8%
Nov 6	Baird	Maintains	Outperform → Outperform	—	$117.83	$89.44	-24.1%	-35.0%	-37.4%	-32.2%	-33.8%	-34.0%
Nov 6	Canaccord Genuity	Maintains	Buy → Buy	—	$117.83	$89.44	-24.1%	-35.0%	-37.4%	-32.2%	-33.8%	-34.0%
Nov 6	Jefferies	Maintains	Buy → Buy	—	$117.83	$89.44	-24.1%	-35.0%	-37.4%	-32.2%	-33.8%	-34.0%
Nov 6	UBS	Maintains	Neutral → Neutral	—	$117.83	$89.44	-24.1%	-35.0%	-37.4%	-32.2%	-33.8%	-34.0%
Nov 6	Piper Sandler	Downgrade	Overweight → Neutral	—	$117.83	$89.44	-24.1%	-35.0%	-37.4%	-32.2%	-33.8%	-34.0%
Nov 6	JP Morgan	Maintains	Overweight → Overweight	—	$117.83	$89.44	-24.1%	-35.0%	-37.4%	-32.2%	-33.8%	-34.0%
Oct 28	Jefferies	Maintains	Buy → Buy	—	$126.18	$127.00	+0.6%	+4.4%	+0.6%	-2.4%	-3.2%	-4.2%
Oct 21	Canaccord Genuity	Maintains	Buy → Buy	—	$127.42	$128.40	+0.8%	-0.2%	-3.0%	-1.9%	-3.6%	-1.0%
Oct 20	Raymond James	Maintains	Strong Buy → Strong Buy	—	$136.92	$136.81	-0.1%	-6.9%	-7.2%	-9.7%	-8.7%	-10.3%
Oct 10	JP Morgan	Maintains	Overweight → Overweight	—	$144.97	$146.51	+1.1%	-10.5%	-8.5%	-8.6%	-7.5%	-6.3%
Oct 8	Morgan Stanley	Maintains	Overweight → Overweight	—	$140.60	$147.75	+5.1%	+3.2%	+3.1%	-7.8%	-5.6%	-5.8%
Oct 8	UBS	Maintains	Neutral → Neutral	—	$140.60	$147.75	+5.1%	+3.2%	+3.1%	-7.8%	-5.6%	-5.8%
Oct 2	Goldman Sachs	Maintains	Buy → Buy	—	$135.20	$135.77	+0.4%	+0.5%	-0.4%	+2.3%	+4.0%	+7.3%
Sep 17	BofA Securities	Maintains	Buy → Buy	—	$143.28	$145.91	+1.8%	+2.0%	+2.4%	-2.3%	-4.2%	-5.0%
Sep 10	B. Riley Securities	Maintains	Buy → Buy	—	$138.83	$139.10	+0.2%	-3.2%	-0.5%	-2.6%	+4.0%	+3.2%
Sep 8	Raymond James	Maintains	Strong Buy → Strong Buy	—	$133.97	$135.63	+1.2%	+3.0%	+3.6%	+0.4%	+3.1%	+0.9%
Sep 2	Deutsche Bank	Downgrade	Buy → Hold	—	$125.00	$120.46	-3.6%	+0.5%	+4.1%	+7.0%	+7.2%	+10.4%
Aug 11	Morgan Stanley	Upgrade	Equal Weight → Overweight	—	$101.77	$107.37	+5.5%	+9.7%	+14.7%	+20.8%	+17.5%	+14.3%
Aug 7	Canaccord Genuity	Maintains	Buy → Buy	—	$110.39	$97.68	-11.5%	-9.5%	-7.8%	+1.2%	+5.8%	+11.4%
Aug 7	UBS	Maintains	Neutral → Neutral	—	$110.39	$97.68	-11.5%	-9.5%	-7.8%	+1.2%	+5.8%	+11.4%
Aug 7	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$110.39	$97.68	-11.5%	-9.5%	-7.8%	+1.2%	+5.8%	+11.4%
Aug 7	Goldman Sachs	Maintains	Buy → Buy	—	$110.39	$97.68	-11.5%	-9.5%	-7.8%	+1.2%	+5.8%	+11.4%
Aug 7	JP Morgan	Maintains	Overweight → Overweight	—	$110.39	$97.68	-11.5%	-9.5%	-7.8%	+1.2%	+5.8%	+11.4%
Jul 25	JP Morgan	Maintains	Overweight → Overweight	—	$119.22	$119.89	+0.6%	+1.4%	+1.5%	+0.6%	+3.4%	+1.7%
Jul 17	UBS	Maintains	Neutral → Neutral	—	$108.51	$108.20	-0.3%	+2.2%	+8.4%	+2.9%	+6.9%	+8.4%
Jul 9	Canaccord Genuity	Maintains	Buy → Buy	—	$116.99	$118.27	+1.1%	+0.6%	-1.4%	-6.0%	-9.4%	-8.7%
Jun 20	BofA Securities	Maintains	Buy → Buy	—	$122.24	$122.32	+0.1%	-2.0%	+0.7%	-0.3%	+2.6%	+2.2%
Jun 13	B. Riley Securities	Maintains	Buy → Buy	—	$128.54	$127.11	-1.1%	-2.6%	-1.8%	-2.3%	-4.9%	-6.8%
Jun 6	Truist	Maintains	Buy → Buy	—	$115.80	$119.42	+3.1%	+1.6%	+0.6%	+1.9%	+7.5%	+11.0%
Jun 6	Baird	Maintains	Outperform → Outperform	—	$115.80	$119.42	+3.1%	+1.6%	+0.6%	+1.9%	+7.5%	+11.0%
Jun 2	Raymond James	Maintains	Strong Buy → Strong Buy	—	$112.49	$112.97	+0.4%	+1.1%	+2.0%	+4.2%	+2.9%	+4.6%
May 30	Truist	Maintains	Buy → Buy	—	$111.84	$112.16	+0.3%	+0.6%	+1.7%	+2.6%	+4.8%	+3.5%
May 30	JP Morgan	Maintains	Overweight → Overweight	—	$111.84	$112.16	+0.3%	+0.6%	+1.7%	+2.6%	+4.8%	+3.5%

Recent Filings

8-K · 5.02 !!! Very High

e.l.f. Beauty, Inc. -- 8-K 5.02: Executive Change

e.l.f. Beauty appointed Matthew Farrell as a Class I director, expanding its board composition and potentially signaling strategic changes in company leadership or direction.

Feb 13

8-K

e.l.f. Beauty, Inc. -- 8-K Filing

e.l.f. Beauty gained 130 basis points of market share in Q3 2025, indicating strong competitive positioning and potential revenue acceleration in the beauty market.

Feb 4

Data updated apr 25, 2026 6:52am · Source: massive.com